On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary.
HOUSTON, Dec. 28, 2022 /PRNewswire/ -- Sempra Infrastructure, a subsidiary of Sempra (NYSE:SRE) (BMV:SRE), today announced it has entered into a long-term sale and purchase agreement (SPA) with
VANGRID, a member of the Iberdrola Group (NYSE:AGR), and Sempra Infrastructure, a subsidiary of Sempra (NYSE:SRE) (BMV:SRE), today announced they have entered into a heads of agreement (HOA) for the